{
    "nct_id": "NCT06037941",
    "official_title": "Breathprinting (E-Nose) Technology to Measure Response to Treatment of Malignant Pleural Mesothelioma (MPM) Through MPM-Specific Volatile Organic Compounds Detected in Exhalates",
    "inclusion_criteria": "* Aged 30-85 years\n* No history of thoracic cancer or extrathoracic cancer potentially involving pleural metastases (i.e., breast, gastric, colon, or pancreas cancer)\n* Recent diagnosis of MPM\n* Documented, signed, and dated informed consent, obtained before any procedures, for the proposed research study, and signed standard surgical consent for surgical resection\nHealthy volunteers allowed\nMust have minimum age of 30 Years\nMust have maximum age of 85 Years",
    "exclusion_criteria": "* Aged <30 or >85 years at the first outpatient visit\n* History of thoracic or extrathoracic cancer that puts the subject at risk for pleural or pulmonary metastases",
    "miscellaneous_criteria": ""
}